BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19654878)

  • 21. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
    Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R
    J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications.
    Di Ianni M; Del Papa B; Cecchini D; Bonifacio E; Moretti L; Zei T; Ostini RI; Falzetti F; Fontana L; Tagliapietra G; Maldini C; Martelli MF; Tabilio A
    Clin Exp Immunol; 2009 May; 156(2):246-53. PubMed ID: 19292855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome.
    Zhu LY; Chi LJ; Wang X; Zhou H
    Clin Exp Immunol; 2009 Apr; 156(1):88-96. PubMed ID: 19210520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology.
    Corsini E; Oukka M; Pieters R; Kerkvliet NI; Ponce R; Germolec DR
    J Immunotoxicol; 2011; 8(4):251-7. PubMed ID: 21848365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis.
    Semple PL; Binder AB; Davids M; Maredza A; van Zyl-Smit RN; Dheda K
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1249-58. PubMed ID: 23590266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated IFN-alpha/beta levels in a streptozotocin-induced type I diabetic mouse model promote oxidative stress and mediate depletion of spleen-homing CD8+ T cells by apoptosis through impaired CCL21/CCR7 axis and IL-7/CD127 signaling.
    Mahmoud MH; Badr G; Badr BM; Kassem AU; Mohamed MS
    Cell Signal; 2015 Oct; 27(10):2110-9. PubMed ID: 26192098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes.
    Jin Y; Chen X; Podolsky R; Hopkins D; Makala LH; Muir A; She JX
    Clin Immunol; 2009 Mar; 130(3):272-9. PubMed ID: 19036642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study.
    Truman LA; Pekalski ML; Kareclas P; Evangelou M; Walker NM; Howlett J; Mander AP; Kennet J; Wicker LS; Bond S; Todd JA; Waldron-Lynch F
    BMJ Open; 2015 Dec; 5(12):e009799. PubMed ID: 26646829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
    Bollyky JB; Long SA; Fitch M; Bollyky PL; Rieck M; Rogers R; Samuels PL; Sanda S; Buckner JH; Hellerstein MK; Greenbaum CJ
    Clin Exp Immunol; 2013 Jun; 172(3):363-74. PubMed ID: 23600824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.
    Long SA; Walker MR; Rieck M; James E; Kwok WW; Sanda S; Pihoker C; Greenbaum C; Nepom GT; Buckner JH
    Eur J Immunol; 2009 Feb; 39(2):612-20. PubMed ID: 19180473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.
    Wang Z; Shi BY; Qian YY; Cai M; Wang Q
    Clin Exp Immunol; 2009 Mar; 155(3):496-503. PubMed ID: 19141125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant TNFα and impaired IL-2 cytokine profiles of CD4
    Seyfarth J; Förtsch K; Ahlert H; Laws HJ; Karges B; Deenen R; Köhrer K; Mayatepek E; Meissner T; Jacobsen M
    Immunol Cell Biol; 2017 Aug; 95(7):630-639. PubMed ID: 28377612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
    Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
    Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD 127- and FoxP3+ expression on CD25+CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients.
    Vrabelova Z; Hrotekova Z; Hladikova Z; Bohmova K; Stechova K; Michalek J
    Scand J Immunol; 2008 Apr; 67(4):404-10. PubMed ID: 18248531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.
    Scalapino KJ; Daikh DI
    PLoS One; 2009 Jun; 4(6):e6031. PubMed ID: 19551149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.
    Yamanouchi J; Puertas MC; Verdaguer J; Lyons PA; Rainbow DB; Chamberlain G; Hunter KM; Peterson LB; Wicker LS; Santamaria P
    Diabetes; 2010 Jan; 59(1):272-81. PubMed ID: 19833887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
    Fecci PE; Sweeney AE; Grossi PM; Nair SK; Learn CA; Mitchell DA; Cui X; Cummings TJ; Bigner DD; Gilboa E; Sampson JH
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4294-305. PubMed ID: 16857805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in type I diabetes associated tolerance mechanisms.
    Chentoufi AA; Binder NR; Berka N; Abunadi T; Polychronakos C
    Scand J Immunol; 2008 Jul; 68(1):1-11. PubMed ID: 18482207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.